Antengene unveils three pipeline programs at AACR 2026 as AnTenGager platform expands beyond UCB deal
Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?
Read More Pharma Industry News Targovax’s ONCOS-102 receives FDA fast track designation for malignant pleural mesothelioma treatment In a significant development for cancer treatment, Targovax, a Norwegian biotech firm specializing in immune-oncology, has announced that… bypharmanewsdailyFebruary 15, 2021
